The Menopausal Toll on the Body with Dr. Sasha Rose
Episode Summary
Cole Siefer sits down with Dr. Sasha Rose, a naturopathic doctor and licensed acupuncturist with 20 years of experience, to map out what menopause actually does to a woman's body. Dr. Rose starts with terminology, separating perimenopause (the 10 to 15 year stretch of declining progesterone and fluctuating estrogen) from menopause itself (defined as 12 consecutive months without a period) and the postmenopausal years that follow. She explains why so many women feel dismissed by conventional care, tracing the gap back to the misinterpreted Women's Health Initiative study and a generation of providers who were never trained in hormone management. The conversation moves through the wide reach of estrogen: mood, sleep, weight and metabolism, muscle mass, joint pain, and even autoimmune flares. Dr. Rose lays out her testing-first, personalized approach, the difference between synthetic and bioidentical hormones, why transdermal estrogen is safer than oral, and how progesterone, testosterone, vaginal estrogen, and peptides each fit a plan. She shares a 52-year-old patient case and answers live questions on HRT after 65, joint pain, and GLP-1 medications. Her closing message is that menopause does not have to be the end of vitality.
Key Topics
- 1
The difference between perimenopause, menopause, and postmenopause
- 2
Why the Women's Health Initiative study left women and providers wary of hormone therapy
- 3
Synthetic hormones versus bioidentical hormones and why route of delivery matters
- 4
How declining estrogen affects mood, serotonin, dopamine, and stress resilience
- 5
The cortisol surge between 2 and 4 a.m. and disrupted perimenopausal sleep
- 6
Why weight gain, insulin resistance, and muscle loss increase during menopause
- 7
Joint pain and autoimmune flares as overlooked hormonal symptoms
- 8
Blood testing for sex hormones and the broader functional lab panel
- 9
Personalizing a plan with progesterone, testosterone, vaginal estrogen, and lifestyle changes
- 10
Peptides such as BPC-157 and the role of GLP-1 medications
Quotable Moments
“Estrogen alone, there's estrogen receptors in the brain, the bones, it affects the blood vessels and the cardiovascular system. The receptors are everywhere, and therefore a change in those hormones is going to be felt everywhere.”
“There's a whole generation of physicians and providers who don't know anything about hormone replacement therapy, and therefore don't really know that much about menopause in general.”
“It's not just vanity, in terms of not liking how it looks. There's also some metabolic risk factors that increase with that weight gain around the middle.”
“Menopause is not the end of the road. It actually can be a time of vitality, and it can be one of maybe the best phases of your life when you're receiving the right amount of support.”
“Women are sadly so often dismissed and gaslit when they try to seek help, and the more that we can change that the better.”
Treatments Mentioned
FAQ
Women's Health FAQ
Dr. Rose explains that perimenopause is the 10 to 15 year stretch before menopause when progesterone steadily declines and estrogen fluctuates. Menopause itself is a single point in time, defined as 12 consecutive months without a menstrual period. After that, a woman is considered postmenopausal, and most symptoms tend to occur during the perimenopausal years.
She points to the Women's Health Initiative study, which was halted and reported as showing increased breast cancer and cardiovascular risk, information we now know was misinterpreted. That left a generation of providers untrained in hormone therapy and menopause. As a result, many women are told it is in their head, that they are just getting older, or are offered an antidepressant while the hormonal piece is overlooked.
Dr. Rose explains that bioidentical hormones are molecularly identical to a woman's own hormones, which improves the safety profile compared to synthetic versions like those used in the original study. She also notes that transdermal estrogen applied to the skin carries no increase in blood clot risk over baseline, while oral estrogen does raise that risk.
Yes. She describes how falling estrogen lowers resting metabolic rate and shifts fat toward the midsection, which can drive insulin resistance. Many women report eating well and exercising as before but still gaining weight around the middle, and she explains this reflects a real metabolic shift rather than a lack of effort.
Dr. Rose says the old thinking that women over 65 or more than 10 years postmenopausal should never start hormone therapy is no longer accurate. When estrogen is given transdermally rather than orally, the blood clot risk does not rise, and progesterone is considered safe at any age. The decision depends on the individual, but many women can still benefit, especially for bone health.
She explains that estrogen is anti-inflammatory and helps keep autoimmune processes in check, so when estrogen drops some women experience flares or new joint pain and stiffness. Joint pain is not usually thought of as hormonal, but it can be a perimenopausal symptom because estrogen also supports the lubrication and elasticity of connective tissue.
Related Service
Learn More
Women's Health
Tired, gaining weight, not sleeping? Med Matrix tests 80+ biomarkers including full hormones, thyroid, and cortisol. Bioidentical HRT, perimenopause care, 60-min visits. 4.9 stars. $100 off.
